Opioid reversal agent naloxone approvable for OTC use – FDA

Nov. 15, 2022 1:37 PM ETPfizer Inc. (PFE)TEVA, EBS, HKMPF, AMPH, OPNTBy: Dulan Lokuwithana, SA News Editor8 Comments

Food And Drug Administration Headquarters In Maryland

Sarah Silbiger

  • The U.S. Food and Drug Administration (FDA) announced Tuesday that certain forms of opioid reversal therapy, naloxone, could be safe and effective for over-the-counter use, potentially opening the door for its switch to nonprescription status.
  • The notice

Recommended For You

Comments (8)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.